通过ENO1,SIX1增强有氧糖解和宫癌的进展

相关实验视频

Updated: May 13, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Xuelian Liu^1,2,3, Hang Ren^1,2,3, Anjin Wang^1,2,3

¹Department of Gynecological Oncology, Zhongnan Hospital, Wuhan University, 169 Donghu Rd, Wuhan, People's Republic of China.

|April 15, 2025

概括

SIX homeobox 1 (SIX1) 通过促进葡萄糖代谢来驱动子宫癌的生长. 准SIX1可能为宫癌患者提供新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

在中国,子宫癌的发病率正在上升,对妇女健康构成重大威胁.
晚期和复发性宫癌的治疗具有挑战性,需要新的治疗点.
SIX homeobox 1 (SIX1) 涉及各种癌症的扩散,转移和化学抵抗.

研究的目的:

研究SIX1在宫癌进展中的调控作用.
探索SIX1影响子宫癌细胞行为的机制.
根据SIX1功能来确定宫癌的潜在治疗点.

主要方法:

在宫癌组织中SIX1表达的分析.
在体外研究评估SIX1对细胞增殖,入侵和迁移的影响.
检查SIX1对葡萄糖代谢和关键糖解酶表达 (GLUT1,PFK1,PGK1,ENO1,PKM2) 的影响.
在ENO1促进区域中识别SIX1结合部位.

主要成果:

宫癌组织中的SIX1过度表达与晚期临床阶段和淋巴结转移有关.
SIX1显著促进子宫癌细胞的增殖,入侵和迁移.
通过调节关键的糖解酶,包括ENO1.1,SIX1可以增强葡萄糖代谢.
SIX1直接与ENO1促进体结合,表明转录调节.

结论:

SIX1在促进宫癌细胞扩散和转移方面发挥着至关重要的作用.
通过转录控制像ENO1.1,SIX1调节宫癌的进展,通过转录控制糖分酶如ENO1.1,增强葡萄糖代谢.
SIX1代表了宫癌治疗的潜在治疗标.

关键词:

宫癌是发生在宫癌的原因之一.在 ENO1 中, ENO1 是 ENO1 的代码.葡萄糖溶解是什么? 葡萄糖溶解第六百一十一章六一

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

相关概念视频

Outcomes of Glycolysis

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Glycolysis: Preparatory Phase

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy), glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...